Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Frantz

Showing results (181-190 of 247) with videos related to

Pageof 25
Sort By:
Pulmonary Circulation|January 9, 2023
Acute vasoreactivity testing during right heart catheterization in chronic thromboembolic pulmonary hypertension: Results from the pulmonary vascular disease phenomics studyRobert P Frantz, Jane A Leopold, Paul M Hassoun, et al.
JACC. Cardiovascular Imaging|June 10, 2026
Prognostic Value of Tricuspid Regurgitation in Pulmonary Hypertension and Among the Different WHO GroupsJwan A Naser, Hossam H Ibrahim, Serena Rahme, et al.
Transplantation|January 18, 2013
Donor-specific antibodies to class II antigens are associated with accelerated cardiac allograft vasculopathy: a three-dimensional volumetric intravascular ultrasound studyYan Topilsky, Manish J Gandhi, Tal Hasin, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|July 8, 2024
Reduction in Balloon Pump Size Reduces Axillary Intraaortic Balloon Pump Failure RiskSara S Inglis, Ardaas Kanwar, Hilda Gonzalez Bonilla, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|January 24, 2017
Early Gains in Renal Function Following Implantation of HeartMate II Left Ventricular Assist Devices May Not Persist to One YearTal Hasin, Avishay Grupper, John J Dillon, et al.
Journal of the American College of Cardiology|December 24, 2011
Changes in renal function after implantation of continuous-flow left ventricular assist devicesTal Hasin, Yan Topilsky, John A Schirger, et al.
Chest|April 30, 2018
Psychometric Validation of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) Questionnaire: Results of the SYMPHONY TrialKelly M Chin, Mardi Gomberg-Maitland, Richard N Channick, et al.
Circulation|December 31, 2011
Sirolimus as primary immunosuppression attenuates allograft vasculopathy with improved late survival and decreased cardiac events after cardiac transplantationYan Topilsky, Tal Hasin, Eugenia Raichlin, et al.
The American Journal of Cardiology|July 24, 2012
Usefulness of the six-minute walk test after continuous axial flow left ventricular device implantation to predict survivalTal Hasin, Yan Topilsky, Walter K Kremers, et al.
Pulmonary Circulation|November 15, 2019
Long-term results of the DelIVery for Pulmonary Arterial Hypertension trialMardi Gomberg-Maitland, Robert C Bourge, Shelley M Shapiro, et al.
Pageof 25

Showing results (181-190 of 247) with videos related to

Sort By:
Pageof 25
Pulmonary Circulation|January 9, 2023
Acute vasoreactivity testing during right heart catheterization in chronic thromboembolic pulmonary hypertension: Results from the pulmonary vascular disease phenomics studyRobert P Frantz, Jane A Leopold, Paul M Hassoun, et al.
JACC. Cardiovascular Imaging|June 10, 2026
Prognostic Value of Tricuspid Regurgitation in Pulmonary Hypertension and Among the Different WHO GroupsJwan A Naser, Hossam H Ibrahim, Serena Rahme, et al.
Transplantation|January 18, 2013
Donor-specific antibodies to class II antigens are associated with accelerated cardiac allograft vasculopathy: a three-dimensional volumetric intravascular ultrasound studyYan Topilsky, Manish J Gandhi, Tal Hasin, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|July 8, 2024
Reduction in Balloon Pump Size Reduces Axillary Intraaortic Balloon Pump Failure RiskSara S Inglis, Ardaas Kanwar, Hilda Gonzalez Bonilla, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|January 24, 2017
Early Gains in Renal Function Following Implantation of HeartMate II Left Ventricular Assist Devices May Not Persist to One YearTal Hasin, Avishay Grupper, John J Dillon, et al.
Journal of the American College of Cardiology|December 24, 2011
Changes in renal function after implantation of continuous-flow left ventricular assist devicesTal Hasin, Yan Topilsky, John A Schirger, et al.
Chest|April 30, 2018
Psychometric Validation of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) Questionnaire: Results of the SYMPHONY TrialKelly M Chin, Mardi Gomberg-Maitland, Richard N Channick, et al.
Circulation|December 31, 2011
Sirolimus as primary immunosuppression attenuates allograft vasculopathy with improved late survival and decreased cardiac events after cardiac transplantationYan Topilsky, Tal Hasin, Eugenia Raichlin, et al.
The American Journal of Cardiology|July 24, 2012
Usefulness of the six-minute walk test after continuous axial flow left ventricular device implantation to predict survivalTal Hasin, Yan Topilsky, Walter K Kremers, et al.
Pulmonary Circulation|November 15, 2019
Long-term results of the DelIVery for Pulmonary Arterial Hypertension trialMardi Gomberg-Maitland, Robert C Bourge, Shelley M Shapiro, et al.
Pageof 25